Martinetti Miryam, Biagi Federico, Badulli Carla, Feurle Gerhard E, Müller Christian, Moos Verena, Schneider Thomas, Marth Thomas, Marchese Alessandra, Trotta Lucia, Sachetto Sara, Pasi Annamaria, De Silvestri Annalisa, Salvaneschi Laura, Corazza Gino R
Immunohematology and Transfusion Centre, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Gastroenterology. 2009 Jun;136(7):2289-94. doi: 10.1053/j.gastro.2009.01.051. Epub 2009 Jan 27.
BACKGROUND & AIMS: Whipple's disease is a systemic, chronic, relapsing disorder caused by a combination of environmental (Tropheryma whipplei) and unknown host factors. Because it is a rare disease, the association between HLA type and Whipple's disease has been studied in only small numbers of patients; these studies have led to conflicting results. We aimed to investigate whether disease phenotype and outcome are associated with HLA type in 122 patients with Whipple's disease.
Genomic DNA was collected from 103 German, 11 Italian, and 8 Austrian patients with Whipple's disease, along with 62 healthy Austrian workers exposed to T whipplei (14 stool samples contained the bacterium). HLA class I and II alleles were identified by polymerase chain reaction analysis. Patient genotypes were compared with those of healthy German and Austrian populations; data for Italian controls were obtained from the Pavia HLA bone marrow donors' bank.
HLA-DRB113 and DQB106 alleles occurred significantly more frequently in patients with Whipple's disease but not in healthy individuals who had been exposed to T Whipplei. The cumulative odds ratios for disease were 2.23 for the DRB113 allele (P < .0001) and 2.25 for the DQB106 allele (P < .0001).
DRB113 and DQB106 alleles were found to be risk factors in the largest HLA study ever performed in patients with Whipple's disease.
惠普尔病是一种由环境因素(惠普尔嗜组织菌)和未知宿主因素共同引起的全身性、慢性、复发性疾病。由于它是一种罕见疾病,仅在少数患者中研究了人类白细胞抗原(HLA)类型与惠普尔病之间的关联;这些研究结果相互矛盾。我们旨在调查122例惠普尔病患者的疾病表型和预后是否与HLA类型相关。
从103名德国、11名意大利和8名奥地利的惠普尔病患者中收集基因组DNA,同时收集62名接触惠普尔嗜组织菌的奥地利健康工作者的DNA(14份粪便样本含有该细菌)。通过聚合酶链反应分析鉴定HLA I类和II类等位基因。将患者的基因型与德国和奥地利健康人群的基因型进行比较;意大利对照的数据来自帕维亚HLA骨髓供体库。
HLA-DRB113和DQB106等位基因在惠普尔病患者中出现的频率明显更高,但在接触惠普尔嗜组织菌的健康个体中未出现这种情况。DRB113等位基因的疾病累积比值比为2.23(P <.0001),DQB106等位基因的疾病累积比值比为2.25(P <.0001)。
在有史以来针对惠普尔病患者进行过的最大规模HLA研究中,发现DRB113和DQB106等位基因是风险因素。